Latest News & Updates

Breaking News

  • 10 minutes ago

  • Simantini Singh Deo

Onco360 Selected By Rigel Pharmaceuticals As Specialty Pharmacy Partner For VEPPANU Breast Cancer Therapy
Breaking News
AscellaHealth Strengthens Leadership to Drive Growth of AscellaOne Pharmacy Platform, Appoints Johanna van Nijkerk as Vice President of Business Development

Vaibhavi M.

Other trending news you may like to read

Onco360 Selected By Rigel Pharmaceuticals As Specialty Pharmacy Partner For VEPPANU Breast Cancer Therapy

Onco360 named specialty pharmacy partner for Rigel's VEPPANU, an FDA-approved therapy for ESR1-mutated advanced breast cancer.

Simantini Singh Deo

Pharma Now

AscellaHealth Strengthens Leadership to Drive Growth of AscellaOne Pharmacy Platform, Appoints Johanna van Nijkerk as Vice President of Business Development

AscellaHealth appoints Johanna van Nijkerk as VP of Business Development to support AscellaOne's growth and expand modern pharmacy benefit solutions.

Vaibhavi M.

Pharma Now

Alamar Biosciences Launches NULISAseq Immune 340 Panel for Advanced Immune Profiling

Alamar Biosciences launches its broadest NULISAseq Immune 340 Panel to advance immune profiling and research across cancer, aging and chronic diseases.

Vaibhavi M.

Pharma Now

NurExone Biologic Appoints David Stolick To Board of Directors, Strengthens Board With Finance and Healthcare Veteran

NurExone appoints David Stolick to its Board, bringing extensive finance, M&A and healthcare leadership experience to the exosome therapy company

Vaibhavi M.

Pharma Now